HongKong:02500

Cardiovalve Submits CE File for Approval Following Successful TARGET Study Completion

Exciting Data on Cardiovalve Tricuspid Valve Replacement Device Presented at PCR London Valves 2025 meeting. LONDON, Nov. 17, 2025 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (2500.HK) today announced that Cardiovalve has submitted the CE technical file for its transcatheter tricuspid valve re...

2025-11-17 17:00 536